Vulnerable groups are less likely to adopt daily HIV preexposure prophylaxis pill than white gay and bisexual men, NBC News reported March 18. Inequities continue to persist in groups who are most ...

When PrEP (pre-exposure prophylaxis), a drug that prevents HIV infection, was first approved by the FDA in 2012, it was a medical breakthrough that promised to drastically reduce HIV transmission.

A decade into the era of the HIV prevention pill, called PrEP, efforts to leverage its heralded power to curb new infections have stagnated in the United States. This shortfall is a key reason the ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

All medicines have side effects – HIV prevention pills are no different. The good news is PrEP (pre-exposure prophylaxis) is extremely effective and generally very safe. Major health authorities ...